[150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global insulin delivery devices market was valued at around USD 16.41 billion in 2021 and is expected to register revenues worth USD 29.1 billion by the end of 2030, growing at an exceptional CAGR of approximately 6.57% between 2022 and 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1802
Insulin Delivery Devices Market Report Scope
A recent study by Precedence Research on the insulin delivery devices market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the insulin delivery devices market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of insulin delivery devices. The study also provides the dynamics that are responsible for influencing the future status of the insulin delivery devices market over the forecast period.
A detailed assessment of the insulin delivery devices market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the insulin delivery devices market along with their product portfolio enhances the reliability of this comprehensive research study.
Competition Landscape
The report has engulfed a chapter on the global insulin delivery devices market’s competitive landscape, which provides detailed analysis and insights on companies offering insulin delivery devices. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.
This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.
Read Also@ Cell Culture Market Size to Worth Around US$ 52.65 Billion by 2030
Some of the Prominent Players in the Insulin Delivery Devices Market Include:
- Novo Nordisk A/S
- Wockhardt Ltd.
- Medtronic
- F. Hoffmann-La Roche, Ltd.
- Abbott Laboratories
- Sanofi
- Eli Lilly and Company
- Biocon Ltd.
- Ypsomed AG
- Becton, Dickinson and Company
Insulin Delivery Devices Market Segmentation
By Type
- Insulin Pumps
- Tubed/Tethered
- Tubeless
- Insulin Pens
- Reusable
- Disposable
- Insulin Pen needles
- Standard
- Safety
- Insulin Jet Injectors
- Insulin Syringes
- Others
By Application
- Type I Diabetes
- Type II Diabetes
By End User
- Home Care
- Hospitals & clinics
- Others
By Distribution Channels
- Online Sales
- Hospital Pharmacies
- Retail Pharmacies
- Other Clinics
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global insulin delivery devices market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the insulin delivery devices market.
The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.
Why should you invest in this report?
If you are aiming to enter the global insulin delivery devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for insulin delivery devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Insulin Delivery Devices Market
5.1. COVID-19 Landscape: Insulin Delivery Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Insulin Delivery Devices Market, By Type
8.1. Insulin Delivery Devices Market, by Type, 2022-2030
8.1.1. Insulin Pumps
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Insulin Pens
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Insulin Pen needles
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Insulin Jet Injectors
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Insulin Delivery Devices Market, By Application
9.1. Insulin Delivery Devices Market, by Application, 2022-2030
9.1.1. Type I Diabetes
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Type II Diabetes
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Insulin Delivery Devices Market, By End User
10.1. Insulin Delivery Devices Market, by End User, 2022-2030
10.1.1. Home Care
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Hospitals & clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Insulin Delivery Devices Market, By Distribution Channels
11.1. Insulin Delivery Devices Market, by Distribution Channels, 2022-2030
11.1.1. Online Sales
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospital Pharmacies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Retail Pharmacies
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Insulin Delivery Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Distribution Channels (2017-2030)
Chapter 13. Company Profiles
13.1. Novo Nordisk A/S
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Wockhardt Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Medtronic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche, Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Abbott Laboratories
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sanofi
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Eli Lilly and Company
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Biocon Ltd.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ypsomed AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Becton, Dickinson and Company
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1802
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com